Search research articles
Contact Us
Filters
Showing results (291-300 of 393) with videos related to
Page
of 40
Sort By:
Cancer Immunology Research
|
June 8, 2019
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Shihong Zhang, Karan Kohli, R Graeme Black, et al.
Gynecologic Oncology
|
June 28, 2017
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
Martee L Hensley, Shreyaskumar R Patel, Margaret von Mehren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2007
Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis
Kay Savage, Maryou B K Lambros, David Robertson, et al.
Eclinicalmedicine
|
October 28, 2025
Health-related quality of life in patients with advanced soft tissue sarcoma receiving first-line palliative chemotherapy (HOLISTIC): longitudinal results from a prospective, observational cohort study
Evelyne Roets, Eugenie Younger, Robin L Jones, et al.
The Lancet. Oncology
|
June 9, 2020
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Jean-Yves Blay, César Serrano, Michael C Heinrich, et al.
Cancers
|
February 15, 2022
Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis
Anne-Rose W Schut, Emma Lidington, Milea J M Timbergen, et al.
Cancers
|
June 24, 2022
Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes
Anne-Rose W Schut, Emma Lidington, Milea J M Timbergen, et al.
Journal of Proteomics
|
April 25, 2021
Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry
Martina Milighetti, Lukas Krasny, Alex T J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1
Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2021
Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour
Suzanne George, Ping Chi, Michael C Heinrich, et al.
Page
of 40
Search research articles
Search
Showing results (291-300 of 393) with videos related to
Sort By:
Page
of 40
Cancer Immunology Research
|
June 8, 2019
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Shihong Zhang, Karan Kohli, R Graeme Black, et al.
Gynecologic Oncology
|
June 28, 2017
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
Martee L Hensley, Shreyaskumar R Patel, Margaret von Mehren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2007
Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis
Kay Savage, Maryou B K Lambros, David Robertson, et al.
Eclinicalmedicine
|
October 28, 2025
Health-related quality of life in patients with advanced soft tissue sarcoma receiving first-line palliative chemotherapy (HOLISTIC): longitudinal results from a prospective, observational cohort study
Evelyne Roets, Eugenie Younger, Robin L Jones, et al.
The Lancet. Oncology
|
June 9, 2020
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Jean-Yves Blay, César Serrano, Michael C Heinrich, et al.
Cancers
|
February 15, 2022
Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis
Anne-Rose W Schut, Emma Lidington, Milea J M Timbergen, et al.
Cancers
|
June 24, 2022
Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes
Anne-Rose W Schut, Emma Lidington, Milea J M Timbergen, et al.
Journal of Proteomics
|
April 25, 2021
Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry
Martina Milighetti, Lukas Krasny, Alex T J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1
Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2021
Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour
Suzanne George, Ping Chi, Michael C Heinrich, et al.
Page
of 40